New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
14:08 EDTVVUSVIVUS Qsymia Q4 patients beter but revenues below Street, says Credit Suisse
Credit Suisse said Qsymia Q4 prescription numbers are better than expected but revenues are likely to come in below consensus. The firm rates shares an Outperform with a $16 price target.
News For VVUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for VVUS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use